Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky A Cameron

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 6, 2006
Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failureAnna P Pilbrow, Barry R Palmer, Chris M Frampton, et al.
Endocrinology|October 19, 2016
Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative SplicingAnna P Pilbrow, Kathy A Lewis, Marilyn H Perrin, et al.
Journal of Cardiovascular Electrophysiology|October 12, 2011
KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patientsBarry R Palmer, C M Frampton, Lorraine Skelton, et al.
Australian and New Zealand Journal of Public Health|June 2, 2011
A Kaupapa Māori approach to a community cohort study of heart disease in New ZealandSuzanne Pitama, J Elisabeth Wells, Allamanda Faatoese, et al.
Scientific Reports|August 22, 2019
Contrasting signals of cardiovascular health among natriuretic peptides in subjects without heart diseaseTimothy C R Prickett, Janet K Spittlehouse, Allison L Miller, et al.
SSM - Population Health|December 25, 2025
Considerations for study design and analysis for ethically and culturally safe DNA methylation research in Aotearoa New ZealandAnna Rolleston, Gregory T Jones, Nikki J Earle, et al.
Plos One|July 14, 2021
Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromesBarry R Palmer, Melinda A Paterson, Chris M Frampton, et al.
European Journal of Heart Failure|July 9, 2024
Plasma soluble fms-like tyrosine kinase-1, placental growth factor, and vascular endothelial growth factor system gene variants as predictors of survival in heart failureMelinda A Paterson, Anna P Pilbrow, Chris M Frampton, et al.
International Journal of Cardiology|August 16, 2014
Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromesAnna P Pilbrow, Lina Cordeddu, Vicky A Cameron, et al.
Circulation. Cardiovascular Genetics|October 11, 2011
Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery diseaseKatrina L Ellis, Chris M Frampton, Anna P Pilbrow, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Hypertension (Dallas, Tex. : 1979)|December 6, 2006
Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failureAnna P Pilbrow, Barry R Palmer, Chris M Frampton, et al.
Endocrinology|October 19, 2016
Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative SplicingAnna P Pilbrow, Kathy A Lewis, Marilyn H Perrin, et al.
Journal of Cardiovascular Electrophysiology|October 12, 2011
KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patientsBarry R Palmer, C M Frampton, Lorraine Skelton, et al.
Australian and New Zealand Journal of Public Health|June 2, 2011
A Kaupapa Māori approach to a community cohort study of heart disease in New ZealandSuzanne Pitama, J Elisabeth Wells, Allamanda Faatoese, et al.
Scientific Reports|August 22, 2019
Contrasting signals of cardiovascular health among natriuretic peptides in subjects without heart diseaseTimothy C R Prickett, Janet K Spittlehouse, Allison L Miller, et al.
SSM - Population Health|December 25, 2025
Considerations for study design and analysis for ethically and culturally safe DNA methylation research in Aotearoa New ZealandAnna Rolleston, Gregory T Jones, Nikki J Earle, et al.
Plos One|July 14, 2021
Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromesBarry R Palmer, Melinda A Paterson, Chris M Frampton, et al.
European Journal of Heart Failure|July 9, 2024
Plasma soluble fms-like tyrosine kinase-1, placental growth factor, and vascular endothelial growth factor system gene variants as predictors of survival in heart failureMelinda A Paterson, Anna P Pilbrow, Chris M Frampton, et al.
International Journal of Cardiology|August 16, 2014
Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromesAnna P Pilbrow, Lina Cordeddu, Vicky A Cameron, et al.
Circulation. Cardiovascular Genetics|October 11, 2011
Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery diseaseKatrina L Ellis, Chris M Frampton, Anna P Pilbrow, et al.
Pageof 8